Stock Events

Stock Events

Sonnet Biotherapeutics (SONN) Q2 2024 Earnings

14MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.9

-0.58

-0.25

0.07

Details

Expected EPS

-0.7

Actual EPS

0.07

Surprise EPS

0.77

Surprise Percent

+110%

Description

Sonnet Biotherapeutics (SONN) has reported earnings of 0.07 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.